2 months ago
LLY
AnalystsTerence FlynnTerence Flynn's Stock Forecasts
AnalystsTerence Flynn
Sectors:
Analyst Ranking
Top 7%
#302 out of 4559 analysts
Average Return
+15.53%
Win Rate
62%46 out of 74
Risk vs Reward
Poor
Good
Terence Flynn's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Translate Bio IncTBIO1 | +147.91% | $15.07 | $37.36 | 2020-10-04 - 2021-09-14 | Strong Buy |
Blueprint Medicines CorpBPMC | +140.20% | $41.34 | $99.30 | 2017-03-12 - 2018-03-13 | Strong Buy |
Eli Lilly & CoLLY | +139.90% | $314.17 | $753.68 | 2023-02-28 - 2024-02-29 | Strong Buy |
Eli Lilly & CoLLY | +106.33% | $367.00 | $757.24 | 2023-04-09 - 2024-04-09 | Strong Buy |
Eli Lilly & CoLLY | +96.90% | $339.08 | $667.65 | 2023-02-02 - 2024-02-02 | Strong Buy |
Terence Flynn Analyst Color
Get additional color on Terence Flynn's coverage of popular stocks
9 months ago
PFE
a year ago
JNJ
a year ago
PFE
a year ago
JNJ
a year ago
LLY
a year ago
JNJ
2 years ago
JNJ
2 years ago
PFE
2 years ago
MRK
2 years ago
JNJ
2 years ago
ABBV
2 years ago
LLY
2 years ago
ABBV
2 years ago
RPRX
Terence Flynn's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Johnson & JohnsonJNJ | 16 | Hold | $167.00 | +11.99% | Maintains | 7 days ago |
Nurix Therapeutics IncNRIX | 3 | Hold | $10.00 | -26.36% | Maintains | 2 months ago |
Crispr Therapeutics AgCRSP | 6 | Strong Sell | $48.00 | -13.76% | Maintains | 2 months ago |
C4 Therapeutics IncCCCC | 5 | Hold | $8.00 | +16.62% | Maintains | 2 months ago |
Eli Lilly & CoLLY | 14 | Strong Buy | $950.00 | +29.90% | Maintains | 2 months ago |
Amgen IncAMGN | 3 | Hold | $278.00 | +2.24% | Maintains | 3 months ago |
Arcus Biosciences IncRCUS | 3 | Strong Buy | $35.00 | +138.42% | Maintains | 5 months ago |
Arvinas IncARVN | 6 | Hold | $20.00 | -42.69% | Maintains | 5 months ago |
Intellia Therapeutics IncNTLA | 4 | Strong Buy | $85.00 | +289.37% | Maintains | 5 months ago |
Royalty Pharma PLCRPRX | 10 | Strong Buy | $57.00 | +104.89% | Maintains | 5 months ago |
United Therapeutics CorpUTHR | 7 | Strong Buy | $314.00 | +34.15% | Maintains | 6 months ago |
Pfizer IncPFE | 12 | Hold | $37.00 | +40.90% | Maintains | 6 months ago |
Abbvie IncABBV | 9 | Strong Buy | $196.00 | +16.74% | Maintains | 6 months ago |
Merck & Co IncMRK | 11 | Hold | $118.00 | -7.04% | Maintains | 6 months ago |
Bristol Myers Squibb CoBMY | 8 | Strong Sell | $50.00 | +1.75% | Maintains | 6 months ago |
Revance Therapeutics IncRVNC | 7 | Hold | $12.00 | +229.67% | Maintains | 6 months ago |
Organon & CoOGN | 7 | Hold | $22.00 | +22.22% | Maintains | 6 months ago |
Blueprint Medicines CorpBPMC | 4 | Strong Buy | $83.00 | -8.40% | Maintains | 9 months ago |
Neuehealth IncNEUE | 1 | Strong Buy | $2,880.00 | N/A | Initiates Coverage On | 3 years ago |
Biogen IncBIIB | 2 | Hold | $436.00 | N/A | Maintains | 3 years ago |
Translate Bio IncTBIO1 | 1 | Strong Buy | $19.00 | N/A | Initiates Coverage On | 4 years ago |
Acceleron Pharma IncXLRN | 2 | Hold | $40.00 | N/A | Upgrades | 6 years ago |
Alnylam Pharmaceuticals IncALNY | 1 | Strong Buy | N/A | N/A | Upgrades | 7 years ago |
Fibrogen IncFGEN | 1 | Hold | N/A | N/A | Downgrades | 7 years ago |
Bioverativ IncBIVV | 1 | Hold | N/A | N/A | Downgrades | 7 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.